CANNABIS GLOBAL INC - CBGL STOCK NEWS

Cannabis Global, Inc. (CBGL) announced a new research initiative to develop methods for infusing food and beverages with psychedelic compounds, including psilocybin and psilocin. The program aims to enhance bioavailability and mask unpleasant tastes of these compounds, leveraging prior infusion research. The company plans to establish a laboratory in a region of California that permits such research. CEO Arman Tabatabei expressed optimism regarding impending legalization of psychedelics, aiming to apply existing infusion techniques to this emerging market. Cannabis Global has filed several patent applications related to its research.

Cannabis Global, Inc. (OTC PINK:CBGL) has secured a trademark for its innovative Comply Bag® from the U.S. Patent and Trademark Office. This product integrates advanced tamper-evident cannabis transport technology with a smartphone app for real-time tracking of shipments. CEO Arman Tabatabaei emphasized the need for modern solutions in cannabis logistics. The Comply Bag® features high-security components and is compliant with regulations in multiple states. The company is also engaged in developing cannabis-related technologies and holds several patents.

Cannabis Global, Inc. (CBGL) and Marijuana Company of America (MCOA) announced support for California's Assembly Bill 45 (AB 45), which establishes a regulatory framework for industrial hemp. Governor Gavin Newsom is expected to sign the bill into law, which would legitimize CBD for human and animal consumption, thus eliminating state prohibition. This law is anticipated to facilitate the production and sale of CBD products in California, presenting significant opportunities for producers in the state, according to company executives.

Marijuana Company of America (MCOA) reported second-quarter financial results for 2021, showcasing total revenues of $16,880, down from $82,958 in 2020. This significant decrease of $66,078 is attributed to new eCommerce sales and reduced market demand due to the COVID-19 pandemic. The company also experienced a net loss of $1,828,117, a 10,830% increase from the previous year's loss. Despite these challenges, MCOA anticipates growth from its recent acquisition of cDistro and partnerships with Cannabis Global Inc. (CBGL) and Eco Innovation Group (ECOX) to enhance THC product manufacturing.

Marijuana Company of America (MCOA) announced its participation in the 2021 Champs Trade Show in Las Vegas from July 27-30. Its subsidiaries, hempSmart and cDistro, will showcase products including the Marley One functional mushroom line, developed in partnership with Silo Wellness (CSE:SILO, OTCQB:SILFF). Both subsidiaries aim to enhance brand visibility and sales, capitalizing on strong recognition, particularly the Marley name. MCOA's joint venture partner, Cannabis Global Inc. (OTC PINK:CBGL), will also exhibit, providing networking opportunities for industry growth.

Cannabis Global (OTC PINK:CBGL) has filed a non-provisional patent application detailing innovative methods for creating highly bioavailable cannabinoids using electrospraying and electrospinning techniques. This includes the development of slow-release and quick-dissolving nanofibers for THC and CBD, which could lead to unique product formulations in the cannabis market. CEO Arman Tabatabaei emphasized the significance of these technologies amidst the potential for nationwide cannabis legalization. However, the company has not yet secured patent protections, and federal laws on psychoactive cannabis remain a concern.

Cannabis Global, Inc. (OTC PINK:CBGL) reported significant financial growth in its third fiscal quarter ending May 31, 2021, with revenues skyrocketing to $940,491 from $26,000 the previous quarter. This increase is attributed to enhanced manufacturing and distribution capabilities, resulting in gross margins of 22.4%. The company also improved total assets to $11.4 million and achieved positive shareholder equity of $3,575,783. Notably, Cannabis Global is expanding through a joint venture and developing its extraction lab to produce premium cannabis concentrates.

Cannabis Global (OTC PINK:CBGL) has previewed preliminary results for the fiscal quarter ended May 31, 2021, forecasting revenue of $940,000, a significant increase from $20,000 in the same period last year. The company attributes this growth to enhanced manufacturing and distribution efforts, alongside newly signed customers. Upcoming product launches, including Diamond Live Resin infused pre-rolls and cannabis-infused edibles, are expected to further boost revenue. The strategic location of Cannabis Global supports its distribution capabilities, creating a competitive advantage.

Cannabis Global Inc. (OTC PINK:CBGL) has announced the upcoming launch of several premium cannabis products through its subsidiary, Natural Plant Extract (NPE). Set for introduction in June, these products include THC-A Diamond, Live Resin-infused pre-rolls, and a new line of vegan cannabis candies. Aimed at the competitive Southern California market, the products boast unique attributes such as ultra-high potency and premium ingredients. The company is also enhancing its distribution capabilities with Northern Light Distribution and progressing toward completing a volatile extraction laboratory in partnership with Marijuana Company of America (OTC PINK:MCOA).